V5 Ultimate
Quality · The complete guide

IEC 62366-1

TL;DR

IEC 62366-1:2015 + A1:2020 (Application of usability engineering to medical devices) is the harmonised standard for human-factors / usability engineering. It defines the Usability Engineering File (UEF), specifies hazard-related use scenarios, prescribes formative and summative evaluations, and links explicitly to ISO 14971 risk management. It is the methodology that FDA, EU MDR notified bodies, Health Canada, PMDA and TGA use to assess whether a medical device's user interface has been designed to minimise use-error and the patient/user risk that follows from it.

Reviewed · By V5 Ultimate compliance team· 2,700 words · ~13 min read

01What IEC 62366-1 is

IEC 62366-1 is the international standard that defines a usability-engineering process for medical devices. It specifies what activities must be performed, what records must be kept, and how the usability work integrates with the device's risk-management file. It is not a usability cookbook — it does not tell you how many participants to recruit or what protocol to run. It tells you what the process must contain and what evidence the regulator will look for.

The 2015 edition was a major rewrite from IEC 62366:2007, splitting the standard into 62366-1 (the requirements) and 62366-2 (the guidance, published as a Technical Report). The 2020 amendment incorporated lessons learned and aligned with the updated ISO 14971:2019.

02The Usability Engineering File

The UEF is the central deliverable. It is a controlled compilation of every usability output — use specification, user-interface specification, hazard-related use scenarios, formative evaluations, summative evaluation, training and labelling decisions, and the linkage to risk-management outputs. It is the inspection-ready evidence that the standard has been applied.

Under EU MDR the UEF feeds the technical documentation directly. Under FDA, the UEF outputs land in the Design History File. Under PMDA and TGA, the UEF is reviewed during the conformity assessment for moderate- and high-risk devices.

03Use specification and user-interface specification

The use specification describes the intended users, intended use environments, intended medical conditions and the operating principles of the device. It anchors every downstream decision: a device intended for trained ICU clinicians has a different usability bar from one intended for self-administration by patients with chronic disease.

The user-interface specification translates the use specification into requirements for the UI — alarms, controls, displays, labelling, instructions for use, training, packaging. Both are controlled documents in the UEF.

05Formative evaluation

Formative evaluations are iterative usability tests during design, used to identify and resolve use-error issues. They are not a regulatory submission deliverable in themselves but the records are part of the UEF and reviewed during inspection.

Typical pattern: 4-8 representative users per round, tested against a prototype or simulated environment, with iterative UI changes between rounds until the design has stabilised. The number of rounds is justified by the residual risk and the complexity of the UI.

06Summative evaluation

Summative evaluation is the validation activity — a study with a final-form (or production-equivalent) device on representative users in a representative environment, designed to demonstrate that the device can be used safely and effectively. It is the headline deliverable that regulators read.

FDA's 2016 guidance and ISO 14971 effectively require a minimum of 15 representative users per distinct user group. The protocol must address every hazard-related use scenario. Use-errors observed during summative must be analysed, root-caused, and either mitigated (UI change, training, labelling) or justified as acceptable residual risk per ISO 14971.

07Training, labelling and the limits of control

Training and labelling are risk controls but the weakest in the hierarchy (inherent safety by design > protective measures > information for safety). 62366-1 explicitly de-prioritises 'add a warning to the IFU' as a mitigation. If a use-error is observed in summative, the first response is to redesign the UI, not to add an instruction.

08UI of Unknown Provenance (UOUP)

UOUP is the usability cousin of SOUP. When a manufacturer reuses a UI element from a legacy or third-party source for which the original usability engineering records do not exist, the manufacturer must perform a documented usability evaluation of the UOUP component as if developing it new. The standard prohibits inheriting unverified UI elements wholesale.

09Post-market and changes

Use-errors reported in complaints, vigilance and PMS feed back into the UEF. A use-error pattern that was not predicted in pre-market usability work triggers re-analysis, and may trigger UI changes. Significant UI changes require new formative work and potentially a new summative.

10How V5 supports IEC 62366-1

11Common pitfalls

  • UEF treated as a one-shot pre-submission document rather than a living file.
  • Hazard-related use scenarios identified but not linked to the risk file.
  • Summative evaluation performed on a non-final-form device.
  • Use-errors mitigated by 'added a warning' rather than UI redesign.
  • UOUP components inherited without documented evaluation.
  • Training claimed as a control without evidence the training is effective.
  • Post-market use-errors closed as complaints without feeding back into the UEF.

Frequently asked questions

Q.Is IEC 62366-1 mandatory?+

It is a harmonised standard under EU MDR and IVDR — compliance gives presumption of conformity with the relevant General Safety and Performance Requirements. FDA references it as a recognised consensus standard. In practice, every moderate- and high-risk medical device uses it.

Q.What is the minimum summative sample size?+

The standard does not prescribe a number. FDA's 2016 guidance effectively requires 15 representative users per distinct user group, and this is the de-facto global minimum. Justifications for fewer are rarely accepted.

Q.Does 62366-1 apply to software-only medical devices (SaMD)?+

Yes. The standard is technology-agnostic. SaMD requires usability engineering against its software UI in the same way a hardware device requires it against its physical UI.

Q.How does 62366-1 relate to IEC 62304?+

62304 governs the software development lifecycle. 62366-1 governs the usability of the resulting UI. They overlap at the software UI and are typically managed together — usability requirements become software requirements; use-related risks become software risk-controls.

Primary sources

Further reading

See IEC 62366-1 working on a real shop floor

V5 Ultimate ships with the IEC 62366-1 controls already wired in — audit trail, e-signatures, validation evidence. Free trial, no credit card, onboard in days, not months.